Our findings of the associations between CIC structure, anti-PD-L1 antibody exposure, and NK cytotoxicity susceptibility suggest that the CIC structure frequency may be a general prognostic factor and an important marker when considering immune therapy for CRC patients. Here, CD274 is linked to colorectal carcinoma.